PMID: 25749031Mar 10, 2015Paper

FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells

Oncotarget
LaTonia D Taliaferro-SmithRuth M O'Regan

Abstract

Triple negative breast cancer (TNBC) is a highly metastatic disease that currently lacks effective prevention and treatment strategies. The insulin-like growth factor 1 receptor (IGF1R) and focal adhesion kinase (FAK) signaling pathways function in numerous developmental processes, and alterations in both are linked with a number of common pathological diseases. Overexpression of IGF1R and FAK are closely associated with metastatic breast tumors. The present study investigated the interrelationship between IGF1R and FAK signaling in regulating the malignant properties of TNBC cells. Using small hairpin RNA (shRNA)-mediated IGF1R silencing methods, we showed that IGF1R is essential for sustaining mesenchymal morphologies of TNBC cells and modulates the expression of EMT-related markers. We further showed that IGF1R overexpression promotes migratory and invasive behaviors of TNBC cell lines. Most importantly, IGF1R-driven migration and invasion is predominantly mediated by FAK activation and can be suppressed using pharmacological inhibitors of FAK. Our findings in TNBC cells demonstrate a novel role of the IGF1R/FAK signaling pathway in regulating critical processes involved in the metastatic cascade. These results may improve t...Continue Reading

References

Oct 23, 1993·Lancet·T M WeinerWilliam G Cance
Jan 1, 1996·Annals of Surgical Oncology·L V OwensWilliam G Cance
Oct 9, 1996·International Journal of Cancer. Journal International Du Cancer·L TremblayS Chevalier
Aug 3, 2005·Nature Reviews. Cancer·Gordon W McLeanMargaret C Frame
Feb 19, 2008·Cancer Research·David SarrióJosé Palacios
Jul 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Nobuyuki WatanabeYoshio Naomoto
Jan 27, 2009·Cancer Metastasis Reviews·Jihe Zhao, Jun-Lin Guan
Jan 29, 2009·Proceedings of the National Academy of Sciences of the United States of America·Apostolos KlinakisArgiris Efstratiadis
May 5, 2009·Cancer Treatment Reviews·Bianca MostertJan Willem Gratama
May 14, 2009·Journal of Cell Science·Alok TomarDavid D Schlaepfer
Jun 24, 2009·Biochemical and Biophysical Research Communications·Sandra AnderssonBita Sehat
Aug 12, 2009·Biochemical and Biophysical Research Communications·Donghang ZhengSteven N Hochwald
Nov 19, 2009·Breast Cancer Research and Treatment·Tisheeka R GrahamRuth M O'Regan
Mar 27, 2010·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Neil K TaunkBruce G Haffty
Jun 3, 2011·The Journal of Clinical Investigation·Brian D LehmannJennifer A Pietenpol
Jun 22, 2011·Molecular Cancer Therapeutics·Tongrui LiuRuth M O'Regan

Citations

Jan 7, 2016·Frontiers in Endocrinology·Priscilla Ludovico da SilvaTommaso Simoncini
Mar 18, 2016·International Journal of Oncology·Iliet PayanSéverine Van Slambrouck
Feb 8, 2019·Journal of Experimental & Clinical Cancer Research : CR·Damiano Cosimo RigiraccioloMarcello Maggiolini
Oct 14, 2016·Endocrine-related Cancer·Aleksandra M Ochnik, Robert C Baxter
Jul 26, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Morteza MotallebnezhadMehdi Yousefi
Mar 20, 2016·American Journal of Physiology. Heart and Circulatory Physiology·Ákos GasparicsAttila Sebe
Sep 8, 2017·International Journal of Molecular Sciences·Julio Cesar M de-Freitas-JuniorSalomé S Pinho
Sep 19, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Morteza MotallebnezhadMehdi Yousefi
Dec 21, 2017·Scientific Reports·Aubrey L MillerKarina J Yoon
Dec 14, 2017·Journal of Cellular Biochemistry·Cecilia Rodriguez-MonterrosasEduardo Pérez Salazar
Aug 17, 2018·International Journal of Molecular Sciences·Armando CeveniniEsther Imperlini
Aug 6, 2019·International Journal of Cancer. Journal International Du Cancer·Anna De VincenzoMaria Patrizia Stoppelli
Oct 8, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Hai-Ting Liu, Peng Gao
May 7, 2019·Nutrition and Cancer·Christian H GuerreroLizbeth López-Carrillo
Apr 8, 2020·Experimental and Therapeutic Medicine·Maosong WuXianluo Liu
Mar 20, 2019·Cancer Research·Orla T CoxRosemary O'Connor
Feb 11, 2021·Cancers·Damiano Cosimo RigiraccioloRosamaria Lappano

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.